Drug Maker's Ploy to Delay Generics: Add a Line to Pill - Wall Street Journal

Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!

BY JONATHAN D. ROCKOFF

In the latest tack by a pharmaceutical maker to delay generic competition, Irish specialty drug maker Warner Chilcott PLC is trying something new: adding a line across the top of a tablet.

The line, or "score," doesn't affect the chemical composition of Warner Chilcott's Doryx medicine for severe acne. Rather, it makes it easier for patients to divide and take the tablets in thirds, according to the company's filing with the U.S. Food and Drug Administration.

If U.S. regulators accept Warner Chilcott's argument, generic drug makers seeking to copy Doryx will have to give their proposed generic versions a makeover ...

BY JONATHAN D. ROCKOFF

In the latest tack by a pharmaceutical maker to delay generic competition, Irish specialty drug maker Warner Chilcott PLC is trying something new: adding a line across the top of a tablet.

The line, or "score," doesn't affect the chemical composition of Warner Chilcott's Doryx medicine for severe acne. Rather, it makes it easier for patients to divide and take the tablets in thirds, according to the company's filing with the U.S. Food and Drug Administration.

If U.S. regulators accept Warner Chilcott's argument, generic drug makers seeking to copy Doryx will have to give their proposed generic versions a makeover ...